Advisor Partners’s Emergent Biosolutions EBS Stock Holding History

Advisor Partners’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,968	Closed	-$203K	–	761
2020 Q3	$203K	Buy	+1,968	New	+$212K	0.02%	624

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Advisor Partners's EBS Position: Q4 2020 in Review

Advisor Partners sold out of Emergent Biosolutions (EBS) in Q4 2020, closing a stake of 1,968 shares — an estimated $203K sold.

Advisor Partners first reported a position in EBS in Q3 2020 and held it in 1 quarter. The position peaked at $203K in Q3 2020. 353 funds tracked by Wall St. Rank hold EBS as of Q4 2020.

Advisor Partners reported no remaining Emergent Biosolutions position as of Q4 2020 after selling out during the quarter.
Advisor Partners sold 1,968 Emergent Biosolutions shares in Q4 2020, an estimated $203K.
Advisor Partners first reported a position in Emergent Biosolutions in Q3 2020 and held it in 1 quarter.
Advisor Partners's Emergent Biosolutions position peaked at $203K in Q3 2020.
353 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2020.

Based on Advisor Partners's 13F filing for Q4 2020, filed 12 Feb 2021.